{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:28:49Z","timestamp":1792654129681,"version":"4.5.0"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mesenchymal stromal cells (MSCs) are an attractive option for cell therapy for type 1 diabetes mellitus (DM). These cells can be obtained from many sources, but bone marrow and adipose tissue are the most studied. MSCs have distinct advantages since they are nonteratogenic, nonimmunogenic and have immunomodulatory functions. Insulin-producing cells (IPCs) can be generated from MSCs by gene transfection, gene editing or directed differentiation. For directed differentiation, MSCs are usually cultured in a glucose-rich medium with various growth and activation factors. The resulting IPCs can control chemically-induced diabetes in immune-deficient mice. These findings are comparable to those obtained from pluripotent cells. PD-L\n                    <jats:sub>1<\/jats:sub>\n                    and PD-L\n                    <jats:sub>2<\/jats:sub>\n                    expression by MSCs is upregulated under inflammatory conditions. Immunomodulation occurs due to the interaction between these ligands and PD-1 receptors on T lymphocytes. If this function is maintained after differentiation, life-long immunosuppression or encapsulation could be avoided. In the clinical setting, two sites can be used for transplantation of IPCs: the subcutaneous tissue and the omentum. A 2-stage procedure is required for the former and a laparoscopic procedure for the latter. For either site, cells should be transplanted within a scaffold, preferably one from fibrin. Several questions remain unanswered. Will the transplanted cells be affected by the antibodies involved in the pathogenesis of type 1 DM? What is the functional longevity of these cells following their transplantation? These issues have to be addressed before clinical translation is attempted.\n                  <\/jats:p>","DOI":"10.1007\/s12015-020-10036-3","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:03:41Z","timestamp":1599131021000},"page":"1156-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["From Mesenchymal Stromal\/Stem Cells to Insulin-Producing Cells: Progress and Challenges"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4329-0346","authenticated-orcid":false,"given":"Mohamed A.","family":"Ghoneim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman F.","family":"Refaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul L.","family":"Elbassiouny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"10036_CR1","doi-asserted-by":"crossref","unstructured":"Roglic, G. (2016). Report on diabetes: a summary. International Journal of noncommunicable disease, 1(1), 3.","DOI":"10.4103\/2468-8827.184853"},{"issue":"2","key":"10036_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2337\/diabetes.49.2.157","volume":"49","author":"B Soria","year":"2000","unstructured":"Soria, B., Roche, E., Bern\u00e1, G., Le\u00f3n-Quinto, T., Reig, J. A., & Mart\u00edn, F. (2000). Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 49(2), 157\u2013162. https:\/\/doi.org\/10.2337\/diabetes.49.2.157.","journal-title":"Diabetes"},{"issue":"5520","key":"10036_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1126\/science.1058866","volume":"292","author":"N Lumelsky","year":"2001","unstructured":"Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., & McKay, R. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292(5520), 1389\u20131394. https:\/\/doi.org\/10.1126\/science.1058866.","journal-title":"Science"},{"issue":"3","key":"10036_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1634\/stemcells.22-3-265","volume":"22","author":"H Segev","year":"2004","unstructured":"Segev, H., Fishman, B., Ziskind, A., Shulman, M., & Itskovitz-Eldor, J. (2004). Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells, 22(3), 265\u2013274. https:\/\/doi.org\/10.1634\/stemcells.22-3-265.","journal-title":"Stem Cells"},{"issue":"5605","key":"10036_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1126\/science.1077838","volume":"299","author":"J Rajagopal","year":"2003","unstructured":"Rajagopal, J., Anderson, W. J., Kume, S., Martinez, O. I., & Melton, D. A. (2003). Insulin staining of ES cell progeny from Insulin uptake. Science, 299(5605), 363. https:\/\/doi.org\/10.1126\/science.1077838.","journal-title":"Science"},{"issue":"7","key":"10036_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1242\/dev.01044","volume":"131","author":"A Kubo","year":"2004","unstructured":"Kubo, A., Shinozaki, K., Shannon, J. M., Kouskoff, V., Kennedy, M., Woo, S., et al. (2004). Development of definitive endoderm from embryonic stem cells in culture. Development, 131(7), 1651\u20131662. https:\/\/doi.org\/10.1242\/dev.01044.","journal-title":"Development"},{"issue":"12","key":"10036_CR7","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/nbt1163","volume":"23","author":"KA D'Amour","year":"2005","unstructured":"D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology, 23(12), 1534\u20131541. https:\/\/doi.org\/10.1038\/nbt1163.","journal-title":"Nature Biotechnology"},{"issue":"4","key":"10036_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., et al. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology, 26(4), 443\u2013452. https:\/\/doi.org\/10.1038\/nbt1393.","journal-title":"Nature Biotechnology"},{"issue":"8","key":"10036_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.5966\/sctm.2015-0058","volume":"4","author":"TC Schulz","year":"2015","unstructured":"Schulz, T. C. (2015). Concise Review: Manufacturing of Pancreatic Endoderm Cells for Clinical Trials in Type 1 Diabetes. Stem cell translational medicine, 4(8), 927\u2013931. https:\/\/doi.org\/10.5966\/sctm.2015-0058.","journal-title":"Stem cell translational medicine"},{"issue":"11","key":"10036_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., et al. (2014). Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nature Biotechnology, 32(11), 1121\u20131133. https:\/\/doi.org\/10.1038\/nbt.3033.","journal-title":"Nature Biotechnology"},{"issue":"2","key":"10036_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca, F. W., Millman, J. R., G\u00fcrtler, M., Segel, M., Dervort, A. V., Ryu, J. H., et al. (2014). Generation of functional human pancreatic \u03b2-cells in vitro. Cell, 159(2), 428\u2013439. https:\/\/doi.org\/10.1016\/j.cell.2014.09.040.","journal-title":"Cell"},{"issue":"2","key":"10036_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1365-2141.1999.01715.x","volume":"107","author":"CM Digirolamo","year":"1999","unstructured":"Digirolamo, C. M., Stokes, D., Colter, D., Phinney, D. G., Class, R., & Prockop, D. J. (1999). Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. British Journal of Haematology, 1999, 107(2), 275\u2013281. https:\/\/doi.org\/10.1046\/j.1365-2141.1999.01715.x.","journal-title":"British Journal of Haematology, 1999"},{"issue":"2","key":"10036_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrm3049","volume":"12","author":"C Nombela-Arrieta","year":"2011","unstructured":"Nombela-Arrieta, C., Ritz, J., & Silberstein, L. E. (2011). The elusive nature and function of mesenchymal stem cells. Nature Reviews of Molecular Cell Biology, 12(2), 126\u2013131. https:\/\/doi.org\/10.1038\/nrm3049.","journal-title":"Nature Reviews of Molecular Cell Biology"},{"issue":"1","key":"10036_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12015-011-9345-4","volume":"9","author":"F Casiraghi","year":"2013","unstructured":"Casiraghi, F., Remuzzi, G., Abbate, M., & Perico, N. (2013). Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem cell reviews and reports, 9(1), 65\u201379. https:\/\/doi.org\/10.1007\/s12015-011-9345-4.","journal-title":"Stem cell reviews and reports"},{"key":"10036_CR15","doi-asserted-by":"publisher","unstructured":"Samsonraj, R. M. Raghunath, M., Nurcombe, V., Hui, J. H., van Wijnen, A. j., et al. (2017), Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Translational Medicine, 6(12), 2173-2185. https:\/\/doi.org\/10.1002\/sctm.17-0129","DOI":"10.1002\/sctm.17-0129"},{"issue":"3","key":"10036_CR16","first-page":"381","volume":"16","author":"AJ Friedenstein","year":"1966","unstructured":"Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. N. (1966). Osteogenesis on transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 16(3), 381\u2013390.","journal-title":"Journal of Embryology and Experimental Morphology"},{"key":"10036_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1242\/jcs.1988.supplement_10.5","volume":"10","author":"M Owen","year":"1988","unstructured":"Owen, M. (1988). Marrow stromal stem cells. Journal of Cell Science, Suppl, 10, 63\u201376. https:\/\/doi.org\/10.1242\/jcs.1988.supplement_10.5.","journal-title":"Journal of Cell Science, Suppl"},{"issue":"5","key":"10036_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan, A. I. (1991). Mesenchymal stem cells. Journal of Orthopaedic Research, 9(5), 641\u2013650. https:\/\/doi.org\/10.1002\/jor.1100090504.","journal-title":"Journal of Orthopaedic Research"},{"issue":"5","key":"10036_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/146532400539305","volume":"2","author":"EM Horwitz","year":"2000","unstructured":"Horwitz, E. M., & Keating, A. (2000). Nonhematopoietic mesenchymal stem cells: what are they? Cytotherapy, 2(5), 387\u2013388. https:\/\/doi.org\/10.1080\/146532400539305.","journal-title":"Cytotherapy"},{"issue":"5","key":"10036_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., et al. (2005). Clarification of the nomenclature for msc: the international society for cellular therapy position statement. Cytotherapy, 7(5), 393\u2013395. https:\/\/doi.org\/10.1080\/14653240500319234.","journal-title":"Cytotherapy"},{"issue":"4","key":"10036_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 8(4), 315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"issue":"4","key":"10036_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12015-007-9001-1","volume":"3","author":"W Wagner","year":"2007","unstructured":"Wagner, W., Ho, D., & A. (2007). Mesenchymal stem cell preparations--comparing apples and oranges. Stem Cell Reviews and Reports, 3(4), 239\u2013248. https:\/\/doi.org\/10.1007\/s12015-007-9001-1.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"6","key":"10036_CR23","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"F Lv","year":"2014","unstructured":"Lv, F., Tuan, R. S., Cheung, K. M., & Leung, V. Y. (2014). Concise review: The surface markers and identity of human mesenchymal stem cells. Stem Cells, 32(6), 1408\u20131419. https:\/\/doi.org\/10.1002\/stem.1681.","journal-title":"Stem Cells"},{"issue":"Pt 7","key":"10036_CR24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1242\/jcs.113.7.1161","volume":"113","author":"A Muraglia","year":"2000","unstructured":"Muraglia, A., Cancedda, R., & Quarto, R. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. Journal of Cell Science, 113(Pt 7), 1161\u20131166.","journal-title":"Journal of Cell Science"},{"issue":"9","key":"10036_CR25","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1182\/blood.V98.9.2615","volume":"98","author":"M Reyes","year":"2001","unstructured":"Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., & Verfaillie, C. M. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 98(9), 2615\u20132625. https:\/\/doi.org\/10.1182\/blood.V98.9.2615.","journal-title":"Blood"},{"issue":"10","key":"10036_CR26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1182\/blood-2008-10-186288","volume":"113","author":"Retraction. Reyes, M., Lund, T., Le","year":"2009","unstructured":"Retraction. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., & Verfaillie, C.M. (2009). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 113(10), 2370. https:\/\/doi.org\/10.1182\/blood-2008-10-186288.","journal-title":"Blood"},{"issue":"2","key":"10036_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20040440","volume":"200","author":"G K\u00f6gler","year":"2004","unstructured":"K\u00f6gler, G., Sensken, S., Airey, J. A., Trapp, T., M\u00fcschen, M., Feldhahn, N., et al. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. Journal of Experimental Medicine, 200(2), 123\u2013135. https:\/\/doi.org\/10.1084\/jem.20040440.","journal-title":"Journal of Experimental Medicine"},{"issue":"Pt 14","key":"10036_CR28","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1242\/jcs.01103","volume":"117","author":"G D'Ippolito","year":"2004","unstructured":"D'Ippolito, G., Diabira, S., Howard, G. A., Menei, P., Roos, B. A., & Schiller, P. C. (2004). Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. Journal of Cell Science, 117(Pt 14), 2971\u20132981. https:\/\/doi.org\/10.1242\/jcs.01103.","journal-title":"Journal of Cell Science"},{"issue":"1","key":"10036_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00441-007-0485-4","volume":"331","author":"M Kucia","year":"2008","unstructured":"Kucia, M., Wysoczynski, M., Ratajczak, J., & Ratajczak, M. Z. (2008). Identification of very small embryonic like (VSEL) stem cells in bone marrow. Cell and Tissue Research, 331(1), 125\u2013134. https:\/\/doi.org\/10.1007\/s00441-007-0485-4.","journal-title":"Cell and Tissue Research"},{"issue":"19","key":"10036_CR30","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1073\/pnas.0911647107","volume":"107","author":"Y Kuroda","year":"2010","unstructured":"Kuroda, Y., Kitada, M., Wakao, S., Nishikawa, K., Tanimura, Y., Makinoshima, H., et al. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proceedings of the National Academy of Sciences of the United States of America, 107(19), 8639\u20138643. https:\/\/doi.org\/10.1073\/pnas.0911647107.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10036_CR31","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/ATVBAHA.109.191643","volume":"30","author":"M Corselli","year":"2010","unstructured":"Corselli, M., Chen, C., Crisan, M., Lazzari, L., & P\u00e9ault, B. (2010). Perivascular Ancestors of Adult Multipotent Stem Cells. Arteriosclerosis Thrombosis and Vascular Biology, 30(6), 1104\u20131109. https:\/\/doi.org\/10.1161\/ATVBAHA.109.191643.","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"issue":"4","key":"10036_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0008-6363(96)00063-6","volume":"32","author":"KK Hirschi","year":"1996","unstructured":"Hirschi, K. K., & D'Amore, P. A. (1996). Pericytes in the microvasculature. Cardiovascular Research, 32(4), 687\u2013698. https:\/\/doi.org\/10.1016\/S0008-6363(96)00063-6.","journal-title":"Cardiovascular Research"},{"issue":"7","key":"10036_CR33","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/stem.1649","volume":"32","author":"JJ Bara","year":"2014","unstructured":"Bara, J. J., Richards, R. G., Alini, M., & Stoddart, M. J. (2014). Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells, 32(7), 1713\u20131723. https:\/\/doi.org\/10.1002\/stem.1649.","journal-title":"Stem Cells"},{"issue":"17","key":"10036_CR34","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1089\/scd.2012.0415","volume":"22","author":"A Blocki","year":"2013","unstructured":"Blocki, A., Wang, Y., Koch, M., Peh, P., Beyer, S., Law, P., et al. (2013). Functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells and Development, 22(17), 2347\u20132355. https:\/\/doi.org\/10.1089\/scd.2012.0415.","journal-title":"Stem Cells and Development"},{"issue":"1","key":"10036_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jdi.12544","volume":"8","author":"X Mu","year":"2017","unstructured":"Mu, X., Ren, L., Yan, H., Zhang, X., Xu, W., & A., et al. (2017). Enhanced differentiation of human amniotic fluid-derived stem cells into insulin-producing cells in vitro. Journal of Diabetes Investigation, 8(1), 34\u201343. https:\/\/doi.org\/10.1111\/jdi.12544.","journal-title":"Journal of Diabetes Investigation"},{"issue":"10","key":"10036_CR36","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1089\/ten.TEA.2008.0579","volume":"15","author":"L Wu","year":"2009","unstructured":"Wu, L., Wang, N., Liu, Y., & Xing Wei, X. (2009). Differentiation of Wharton\u2019s Jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Engineering Part A, 15(10), 2865\u20132873. https:\/\/doi.org\/10.1089\/ten.TEA.2008.0579.","journal-title":"Tissue Engineering Part A"},{"issue":"3","key":"10036_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3727\/096368910X522270","volume":"20","author":"H Wang","year":"2011","unstructured":"Wang, H., Shyu, J., Shen, W., Hsu, H., Chi, T., et al. (2011). Transplantation of insulin-producing cells derived from umbilical cord stromal cord stromal mesenchymal stem cells to treat NOD Mice. Cell Transplantation, 20(3), 455\u2013466. https:\/\/doi.org\/10.3727\/096368910X522270.","journal-title":"Cell Transplantation"},{"issue":"5","key":"10036_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1615\/CritRevBiomedEng.2018027377","volume":"46","author":"B Chandravanshi","year":"2018","unstructured":"Chandravanshi, B., & Bhonde, R. R. (2018). Human umbilical cord-derived stem cells: isolation, characterization, differentiation, and application in treating diabetes. Critical Reviews in Biomedical Engineering, 46(5), 399\u2013412. https:\/\/doi.org\/10.1615\/CritRevBiomedEng.2018027377.","journal-title":"Critical Reviews in Biomedical Engineering"},{"key":"10036_CR39","unstructured":"Samani, F. S., Ebrahimi, M., Zandieh, T., Khoshchehreh, R., Baghaban, Eslaminejad, M. B., et al. (2015). In vitro differentiation of human umbilical cord blood cd133 (+) cells into insulin producing cells in co-culture with rat pancreatic mesenchymal stem cells. Cell Journal, 17(2), 211-220. 10.22074\/cellj.2016.3717"},{"issue":"5","key":"10036_CR40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1634\/stemcells.22-5-649","volume":"22","author":"Y Fukuchi","year":"2004","unstructured":"Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004). Human placenta-derived cells have mesenchymal stem\/progenitor cell potential. Stem Cells, 22(5), 649\u2013658. https:\/\/doi.org\/10.1634\/stemcells.22-5-649.","journal-title":"Stem Cells"},{"issue":"9","key":"10036_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00029330-200705010-00007","volume":"120","author":"Y Sun","year":"2007","unstructured":"Sun, Y., Chen, L., Hou, X., Hou, W., Dong, J., Sun, L., et al. (2007). Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chinese Medical Journal, 120(9), 771\u2013776.","journal-title":"Chinese Medical Journal"},{"issue":"1","key":"10036_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3727\/096368912X647162","volume":"22","author":"MM Gabr","year":"2013","unstructured":"Gabr, M. M., Zakaria, M. M., Refaie, A. F., Ismail, A. M., Abou-El-Mahasen, M. A., Ashamallah, S. A., et al. (2013). Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplantation, 22(1), 133\u2013145. https:\/\/doi.org\/10.3727\/096368912X647162.","journal-title":"Cell Transplantation"},{"key":"10036_CR43","doi-asserted-by":"publisher","first-page":"628591","DOI":"10.1155\/2014\/628591","volume":"2014","author":"P Czubak","year":"2014","unstructured":"Czubak, P., Bojarska-Junak, A., Tabarkiewicz, J., & Putowski, L. (2014). A modified method of insulin producing cells' generation from bone marrow-derived mesenchymal stem cells. Journal of Diabetes Research, 2014, 628591. https:\/\/doi.org\/10.1155\/2014\/628591.","journal-title":"Journal of Diabetes Research"},{"issue":"1","key":"10036_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tice.2014.11.005","volume":"47","author":"L Khorsandi","year":"2015","unstructured":"Khorsandi, L., Nejad-Dehbashi, F., Ahangarpour, A., & Hashemitabar, M. (2015). Three-dimensional differentiation of bone marrow derived mesenchymal stem cells into insulin-producing cells. Tissue and Cell, 47(1), 66\u201372. https:\/\/doi.org\/10.1016\/j.tice.2014.11.005.","journal-title":"Tissue and Cell"},{"issue":"1","key":"10036_CR45","doi-asserted-by":"publisher","first-page":"e 0145838","DOI":"10.1371\/journal.pone.0145838","volume":"11","author":"Y Xin","year":"2016","unstructured":"Xin, Y., Jiang, X., Wang, Y., Su, X., Sun, M., Zhang, L., et al. (2016). Insulin-producing cells differentiated from human bone marrow mesenchymal stem cells in vitro ameliorate streptozotocin-induced diabetic hyperglycemia. PLoS One, 11(1), e 0145838. https:\/\/doi.org\/10.1371\/journal.pone.0145838.","journal-title":"PLoS One"},{"issue":"6","key":"10036_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11626-019-00358-z","volume":"55","author":"G Daryabor","year":"2019","unstructured":"Daryabor, G., Shiri, E. H., & Kamali-Sarvestani, E. (2019). A simple method for the generation of insulin producing cells from bone marrow mesenchymal stem cells. In Vitro Cellular & Developmental Biology \u2013 Animal, 55(6), 462\u2013471. https:\/\/doi.org\/10.1007\/s11626-019-00358-z.","journal-title":"In Vitro Cellular & Developmental Biology \u2013 Animal"},{"issue":"4","key":"10036_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2006.01.072","volume":"341","author":"K Timper","year":"2006","unstructured":"Timper, K., Seboek, D., Eberhardt, M., Linscheid, P., Christ-Crain, M., Keller, U., et al. (2006). Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochemical and Biophysical Research Communications, 341(4), 135\u2013140. https:\/\/doi.org\/10.1016\/j.bbrc.2006.01.072.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10036_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13105-012-0228-1","volume":"69","author":"PR Moshtagh","year":"2013","unstructured":"Moshtagh, P. R., Emami, S. H., & Sharifi, A. M. (2013). Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study. Journal of physiology and biochemistry, 69(3), 451\u2013458. https:\/\/doi.org\/10.1007\/s13105-012-0228-1.","journal-title":"Journal of physiology and biochemistry"},{"issue":"5","key":"10036_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jcyt.2013.01.005","volume":"15","author":"E Karaoz","year":"2013","unstructured":"Karaoz, E., Okcu, A., \u00dcnal, Z. S., Subasi, C., Saglam, O., & Duruksu, G. (2013). Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo. Cytotherapy, 15(5), 557\u2013570. https:\/\/doi.org\/10.1016\/j.jcyt.2013.01.005.","journal-title":"Cytotherapy"},{"issue":"3","key":"10036_CR50","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbrc.2014.08.121","volume":"452","author":"C Sawangmake","year":"2014","unstructured":"Sawangmake, C., Nowwarote, N., Pavasant, P., Chansiripornchai, P., & Osathanon, T. (2014). A feasibility study of an in vitro differentiation potential toward insulin-producing cells by dental tissue-derived mesenchymal stem cells. Biochemical and Biophysical Research Communications, 452(3), 581\u2013587. https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.121.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10036_CR51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.14712\/fb2017063040132","volume":"63","author":"J Suchanek","year":"2017","unstructured":"Suchanek, J., Nasry, S. A., & Soukup, T. (2017). The differentiation potential of human natal dental pulp stem cells into insulin-producing cells. Folia Biologica (Praha), 63(4), 132\u2013138.","journal-title":"Folia Biologica (Praha)"},{"issue":"1-3","key":"10036_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.diff.2015.08.001","volume":"90","author":"S Kim","year":"2015","unstructured":"Kim, S., Kim, Y., Park, W., Kim, H. S., Jung, S., Woo, S., et al. (2015). Characterization of insulin-producing cells differentiated from tonsil derived mesenchymal stem cells. Differentiation, 90(1-3), 27\u201339. https:\/\/doi.org\/10.1016\/j.diff.2015.08.001.","journal-title":"Differentiation"},{"issue":"11","key":"10036_CR53","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/mt.2011.173","volume":"19","author":"X Santamaria","year":"2011","unstructured":"Santamaria, X., Massasa, E. E., Feng, Y., Wolff, E., & Taylor, H. S. (2011). Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Molecular Therapy, 19(11), 2065\u20132071. https:\/\/doi.org\/10.1038\/mt.2011.173.","journal-title":"Molecular Therapy"},{"issue":"10","key":"10036_CR54","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/TP.0000000000000388","volume":"98","author":"LT Dao","year":"2014","unstructured":"Dao, L. T., Park, E., Lim, S., Choi, Y., Jung, H. S., & Jun, H. (2014). Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice. Transplantation, 98(10), 1040\u20131047. https:\/\/doi.org\/10.1097\/TP.0000000000000388.","journal-title":"Transplantation"},{"issue":"4","key":"10036_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5966\/sctm.2014-0150","volume":"4","author":"S Shaowei Li","year":"2015","unstructured":"Shaowei Li, S., Huang, K., Wu, J., Hu, M. S., Sanyal, M., Hu, M., et al. (2015). Peripheral blood-derived mesenchymal stem cells: candidate cells responsible for healing critical-sized calvarial bone defects. Stem Cells Translational Medicine, 4(4), 359\u2013368. https:\/\/doi.org\/10.5966\/sctm.2014-0150.","journal-title":"Stem Cells Translational Medicine"},{"issue":"6","key":"10036_CR56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.beem.2015.10.006","volume":"29","author":"I Meivar-Levy","year":"2015","unstructured":"Meivar-Levy, I., & Ferber, S. (2015). Reprogramming of liver cells into insulin-producing cells. Best Practice & Research Clinical Endocrinology & Metabolism, 29(6), 873\u2013882. https:\/\/doi.org\/10.1016\/j.beem.2015.10.006.","journal-title":"Best Practice & Research Clinical Endocrinology & Metabolism"},{"issue":"3","key":"10036_CR57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2302\/kjm.54.132","volume":"54","author":"BM Strem","year":"2005","unstructured":"Strem, B. M., Hicok, K. C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R. E., et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. The Keio Journal of Medicine, 54(3), 132\u2013141. https:\/\/doi.org\/10.2302\/kjm.54.132.","journal-title":"The Keio Journal of Medicine"},{"issue":"3","key":"10036_CR58","first-page":"220","volume":"12","author":"H Ranjbaran","year":"2018","unstructured":"Ranjbaran, H., Abediankenari, S., Khalilian, A., Rahmani, Z., Momeninezhad Amiri, M., & Hosseini Khah, Z. (2018). Differentiation of Wharton's Jelly derived Mesenchymal stem cells into insulin producing cells. International Journal of Hematology-Oncology and Stem Cell Research, 12(3), 220\u2013229.","journal-title":"International Journal of Hematology-Oncology and Stem Cell Research"},{"key":"10036_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcell.2020.00016","volume":"8","author":"MM Kamal","year":"2020","unstructured":"Kamal, M. M., & Kassem, D. H. (2020). Therapeutic potential of Wharton's Jelly mesenchymal stem cells for diabetes: achievements and challenges. Frontiers in cell and developmental biology, 8, 16. https:\/\/doi.org\/10.3389\/fcell.2020.00016.","journal-title":"Frontiers in cell and developmental biology"},{"issue":"1","key":"10036_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001451","volume":"3","author":"KC Chao","year":"2008","unstructured":"Chao, K. C., Chao, K. F., Fu, Y. S., & Liu, S. H. (2008). Islet-like clusters derived from mesenchymal stem cells in Wharton\u2019s Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS one, 3(1), e1451. https:\/\/doi.org\/10.1371\/journal.pone.0001451.","journal-title":"PLoS one"},{"key":"10036_CR61","doi-asserted-by":"publisher","first-page":"3854232","DOI":"10.1155\/2017\/3854232","volume":"2017","author":"MM Gabr","year":"2017","unstructured":"Gabr, M. M., Zakaria, M. M., Refaie, A. F., Abdel-Rahman, E. A., Reda, A. M., Ali, S. S., et al. (2017). From human mesenchymal stem cells to insulin-producing cells: comparison between bone marrow- and adipose tissue-derived cells. Biomed Research International, 2017, 3854232. https:\/\/doi.org\/10.1155\/2017\/3854232.","journal-title":"Biomed Research International"},{"issue":"4-5","key":"10036_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3727\/096368914X678292","volume":"23","author":"T Chan","year":"2014","unstructured":"Chan, T., Harn, H., Lin, H., Chou, P., Chen, J., Ho, T., et al. (2014). Improved human mesenchymal stem cell isolation. Cell Transplantation, 23(4-5), 399\u2013406. https:\/\/doi.org\/10.3727\/096368914X678292.","journal-title":"Cell Transplantation"},{"key":"10036_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4939-6921-0_13","volume":"1590","author":"I Ferrin","year":"2017","unstructured":"Ferrin, I., Beloqui, I., Zabaleta, L., Salcedo, J. M., Trigueros, C., & Martin, A. G. (2017). Isolation, culture, and expansion of mesenchymal stem cells. Methods in Molecular Biology (Clifton, N.J.), 1590, 177\u2013190. https:\/\/doi.org\/10.1007\/978-1-4939-6921-0_13.","journal-title":"Methods in Molecular Biology (Clifton, N.J.)"},{"key":"10036_CR64","volume-title":"Novel diabetes therapy: The seven pillars of credibility","author":"R Calne","year":"2010","unstructured":"Calne, R., & Ghoneim, M. A. (2010). Novel diabetes therapy: The seven pillars of credibility. Treatment Strategies Diabetes. www.treatmentstrategies.co.uk\/diabetes.html"},{"issue":"30","key":"10036_CR65","doi-asserted-by":"publisher","first-page":"e1734","DOI":"10.1371\/journal.pone.0001734","volume":"3","author":"NK Chen","year":"2008","unstructured":"Chen, N. K., Wong, J. S., Kee, I. H., Lai, S. H., Thng, C. H., Ng, W. H., et al. (2008). Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model. PLoS One, 3(30), e1734. https:\/\/doi.org\/10.1371\/journal.pone.0001734.","journal-title":"PLoS One"},{"issue":"9","key":"10036_CR66","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s00125-007-0722-0","volume":"50","author":"B Ren","year":"2007","unstructured":"Ren, B., O'Brien, B. A., Swan, M. A., Koina, M. E., Nassif, N., Wei, M. Q., et al. (2007). Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia, 50(9), 1910\u20131920. https:\/\/doi.org\/10.1007\/s00125-007-0722-0.","journal-title":"Diabetologia"},{"issue":"11","key":"10036_CR67","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1634\/stemcells.2007-0164","volume":"25","author":"O Karnieli","year":"2007","unstructured":"Karnieli, O., Izhar-Prato, Y., Bulvik, S., & Efrat, S. (2007). Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells, 25(11), 2837\u20132844. https:\/\/doi.org\/10.1634\/stemcells.2007-0164.","journal-title":"Stem Cells"},{"key":"10036_CR68","doi-asserted-by":"publisher","unstructured":"Guo, Q. S., Zhu, M. Y., Wang, L., Fan, X. J., Lu, Y. H., Wang, Z. W., et al. (2012). Combined transfection of the three transcriptional factors, pdx-1, neurod1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells. Experimental Diabetes Research, 2012, https:\/\/doi.org\/10.1155\/2012\/672013.","DOI":"10.1155\/2012\/672013"},{"issue":"4","key":"10036_CR69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4252\/wjsc.v5.i4.217","volume":"5","author":"ZN Boroujeni","year":"2013","unstructured":"Boroujeni, Z. N., & Aleyasin, A. (2013). Insulin producing cells established using non-integrated lentiviral vector harboring PDX1 gene. World Journal of Stem Cells, 5(4), 217\u2013228. https:\/\/doi.org\/10.4252\/wjsc.v5.i4.217.","journal-title":"World Journal of Stem Cells"},{"issue":"7","key":"10036_CR70","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3727\/096368914X679363","volume":"24","author":"HV Thi Do","year":"2015","unstructured":"Thi Do, H. V., Loke, V. T., Kee, I., Liang, V., David, S. J., Gan, S. U., et al. (2015). Characterization of insulin-secreting porcine bone marrow stromal cells ex vivo and autologous cell therapy in vivo. Cell Transplantation, 24(7), 1205\u20131220. https:\/\/doi.org\/10.3727\/096368914X679363.","journal-title":"Cell Transplantation"},{"issue":"6","key":"10036_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128650","volume":"10","author":"A Jafarian","year":"2015","unstructured":"Jafarian, A., Taghikani, M., Abroun, S., Allahverdi, A., Lamei, M., Lakpour, N., et al. (2015). The generation of insulin producing cells from human mesenchymal stem cells by MiR-375 and Anti-MiR-9. PLoS One, 10(6), e0128650. https:\/\/doi.org\/10.1371\/journal.pone.0128650.","journal-title":"PLoS One"},{"issue":"12","key":"10036_CR72","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1002\/term.2259","volume":"11","author":"C Bai","year":"2017","unstructured":"Bai, C., Gao, Y., Li, X., Wang, K., Xiong, H., Shan, Z., et al. (2017). MicroRNAs can effectively induce formation of insulin-producing cells from mesenchymal stem cells. Journal of Tissue Engineering and Regenerative Medicine, 11(12), 3457\u20133468. https:\/\/doi.org\/10.1002\/term.2259.","journal-title":"Journal of Tissue Engineering and Regenerative Medicine"},{"issue":"6","key":"10036_CR73","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2337\/db05-1615","volume":"55","author":"A Mas","year":"2006","unstructured":"Mas, A., Montan\u00e9, J., Anguela, X. M., Mu\u00f1oz, S., Douar, A. M., Riu, E., et al. (2006). Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes, 55(6), 1546\u20131553. https:\/\/doi.org\/10.2337\/db05-1615.","journal-title":"Diabetes"},{"issue":"5","key":"10036_CR74","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2337\/db12-1113","volume":"62","author":"D Callejas","year":"2013","unstructured":"Callejas, D., Mann, C. J., Ayuso, E., Lage, R., Grifoll, I., Roca, C., et al. (2013). Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy. Diabetes, 62(5), 1718\u20131729. https:\/\/doi.org\/10.2337\/db12-1113.","journal-title":"Diabetes"},{"key":"10036_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2017.03.008","volume":"6","author":"ML Ja\u00e9n","year":"2017","unstructured":"Ja\u00e9n, M. L., Vil\u00e0, L., Elias, I., Jimenez, V., Rod\u00f3, J., Maggioni, L., et al. (2017). Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: 8-year follow-up in dogs. Molecular Therapy - Methods & Clinical Development, 6, 1\u20137. https:\/\/doi.org\/10.1016\/j.omtm.2017.03.008.","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"key":"10036_CR76","doi-asserted-by":"publisher","unstructured":"Benabdellah, K., S\u00e1nchez-Hern\u00e1ndez, S., Aguilar-Gonz\u00e1lez, A., Maldonado-P\u00e9rez, N., Gutierrez-Guerrero, A., Cortijo-Gutierrez, M., et al. (2020). Genome-edited adult stem cells: next-generation advanced therapy medicinal products (ATMPs). Stem Cells Translational Medicine, 6, [Online ahead of print]. https:\/\/doi.org\/10.1002\/sctm.19-0338.","DOI":"10.1002\/sctm.19-0338"},{"issue":"6121","key":"10036_CR77","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L., Ran, F. A., Co, D., Lin, S., Barreto, R., Habib, N., et al. (2013). Multiplex genome engineering using CRISPR\/Gas systems. Science, 339(6121), 819\u2013823. https:\/\/doi.org\/10.1126\/science.1231143.","journal-title":"Science"},{"issue":"6121","key":"10036_CR78","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., et al. (2013). RNA-guided human genome engineering via Cas9. Science, 339(6121), 823\u2013826. https:\/\/doi.org\/10.1126\/science.1232033.","journal-title":"Science"},{"issue":"6","key":"10036_CR79","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and applications of CRISPR- Cas9 for genome engineering. Cell, 157(6), 1262\u20131278. https:\/\/doi.org\/10.1016\/j.cell.2014.05.010.","journal-title":"Cell"},{"issue":"19","key":"10036_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku749","volume":"42","author":"AM Kabadi","year":"2014","unstructured":"Kabadi, A. M., Ousterout, D. G., Hilton, I. B., & Gersbach, C. A. (2014). Multiplex CRISPR\/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Research, 42(19), e147. https:\/\/doi.org\/10.1093\/nar\/gku749.","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10036_CR81","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/gt.2016.28","volume":"23","author":"CA Gim\u00e9nez","year":"2016","unstructured":"Gim\u00e9nez, C. A., Ielpi, M., Mutto, A., Grosembacher, L., Argibay, P., & Pereyra-Bonnet, F. (2016). CRISPR-on system for the activation of the endogenous human INS gene. Gene Therapy, 23(6), 543\u2013547. https:\/\/doi.org\/10.1038\/gt.2016.28.","journal-title":"Gene Therapy"},{"issue":"6","key":"10036_CR82","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.stem.2016.03.015","volume":"18","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z., Li, Q. V., Lee, K., Rosen, B. P., Gonz\u00e1lez, F., Soh, C., et al. (2016). Genome editing of lineage determinants in human pluripotent stem cells reveals mechanisms of pancreatic development and diabetes. Cell Stem Cell, 18(6), 755\u2013768. https:\/\/doi.org\/10.1016\/j.stem.2016.03.015.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10036_CR83","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.stemcr.2018.11.006","volume":"11","author":"S Ma","year":"2018","unstructured":"Ma, S., Viola, R., Sui, L., Cherubini, V., Barbetti, F., & Egli, D. (2018). \u03b2 cell replacement after gene editing of a neonatal diabetes-causing mutation at the insulin locus. Stem Cell, 11(6), 1407\u20131415. https:\/\/doi.org\/10.1016\/j.stemcr.2018.11.006.","journal-title":"Stem Cell"},{"issue":"5","key":"10036_CR84","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1172\/JCI5298","volume":"103","author":"S Makino","year":"1999","unstructured":"Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., et al. (1999). Cardiomyocytes canbe generated from marrow stromal cells in vitro. Clinical Investigations, 103(5), 697\u2013705. https:\/\/doi.org\/10.1172\/JCI5298.","journal-title":"Clinical Investigations"},{"issue":"3","key":"10036_CR85","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","volume":"22","author":"J Oswald","year":"2004","unstructured":"Oswald, J., Boxberger, S., J\u00f8rgensen, B., Feldmann, S., Ehninger, G., Bornh\u00e4user, M., et al. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22(3), 377\u2013384. https:\/\/doi.org\/10.1634\/stemcells.22-3-377.","journal-title":"Stem Cells"},{"issue":"3","key":"10036_CR86","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/stemcells.2008-0963","volume":"27","author":"S Snykers","year":"2009","unstructured":"Snykers, S., Kock, J. D., Rogiers, V., & Vanhaecke, T. (2009). In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells, 27(3), 577\u2013605. https:\/\/doi.org\/10.1634\/stemcells.2008-0963.","journal-title":"Stem Cells"},{"issue":"7","key":"10036_CR87","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2337\/diabetes.53.7.1721","volume":"53","author":"DQ Tang","year":"2004","unstructured":"Tang, D. Q., Cao, L. Z., Burkhardt, B. R., Xia, C. Q., Litherland, S. A., Atkinson, M. A., et al. (2004). In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes, 53(7), 1721\u20131732. https:\/\/doi.org\/10.2337\/diabetes.53.7.1721.","journal-title":"Diabetes"},{"issue":"20","key":"10036_CR88","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3748\/wjg.v10.i20.3016","volume":"10","author":"LB Chen","year":"2004","unstructured":"Chen, L. B., Jiang, X. B., & Yang, L. (2004). Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World Journal of Gastroenterology, 10(20), 3016\u20133020. https:\/\/doi.org\/10.3748\/wjg.v10.i20.3016.","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10036_CR89","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/labinvest.3700074","volume":"84","author":"SH Oh","year":"2004","unstructured":"Oh, S. H., Muzzonigro, T. M., Bae, S. H., LaPlante, J. M., Hatch, H. M., & Petersen, B. E. (2004). Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Laboratory Investigations., 84(5), 607\u2013617. https:\/\/doi.org\/10.1038\/labinvest.3700074.","journal-title":"Laboratory Investigations."},{"issue":"8","key":"10036_CR90","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/stem.117","volume":"27","author":"VG Chandra","year":"2009","unstructured":"Chandra, V. G., Phadnis, S., Nair, P. D., & Bhonde, R. R. (2009). Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells, 27(8), 1941\u20131953. https:\/\/doi.org\/10.1002\/stem.117.","journal-title":"Stem Cells"},{"key":"10036_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygcen.2013.04.009","volume":"189","author":"H Takemitsu","year":"2013","unstructured":"Takemitsu, H., Zhao, D., Ishikawa, S., Michishita, M., Arai, T., & Yamamoto, I. (2013). Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells. General and Comparative Endocrinology, 189, 1\u20136. https:\/\/doi.org\/10.1016\/j.ygcen.2013.04.009.","journal-title":"General and Comparative Endocrinology"},{"issue":"5","key":"10036_CR92","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.3892\/mmr.2015.4305","volume":"12","author":"Y Sun","year":"2015","unstructured":"Sun, Y., Zhang, M., Ji, S., & Liu, L. (2015). Induction differentiation of rabbit adipose derived stromal cells into insulin producing cells in vitro. Molecular Medicine Reports, 12(5), 6835\u20136840. https:\/\/doi.org\/10.3892\/mmr.2015.4305.","journal-title":"Molecular Medicine Reports"},{"key":"10036_CR93","doi-asserted-by":"publisher","first-page":"832736","DOI":"10.1155\/2014\/832736","volume":"2014","author":"MM Gabr","year":"2014","unstructured":"Gabr, M. M., Zakaria, M. M., Refaie, A. F., Khater, S. M., Ashamallah, S. A., Ismail, A. M., et al. (2014). Generation of insulin-producing cells from human bone marrow-derived mesenchymal stem cells: comparison of three differentiation protocols. Biomed Research International, 2014, 832736. https:\/\/doi.org\/10.1155\/2014\/832736.","journal-title":"Biomed Research International"},{"issue":"12","key":"10036_CR94","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1634\/stemcells.2006-0109","volume":"24","author":"T Thatava","year":"2006","unstructured":"Thatava, T., Ma, B., Rohde, M., & Mayer, H. (2006). Chromatin-remodeling factors allow differentiation of bone marrow cells into insulin-producing cells. Stem Cells, 24(12), 2858\u20132867. https:\/\/doi.org\/10.1634\/stemcells.2006-0109.","journal-title":"Stem Cells"},{"key":"10036_CR95","doi-asserted-by":"publisher","first-page":"575837","DOI":"10.1155\/2015\/575837","volume":"2015","author":"MM Gabr","year":"2015","unstructured":"Gabr, M. M., Zakaria, M. M., Refaie, A. F., Khater, S. M., Ashamallah, S. A., Ismail, A. M., et al. (2015). Differentiation of human bone marrow derived mesenchymal stem cells into insulin-producing cells: evidence for further maturation in vivo. Biomed Research International, 2015, 575837. https:\/\/doi.org\/10.1155\/2015\/575837.","journal-title":"Biomed Research International"},{"issue":"5","key":"10036_CR96","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1002\/jcp.26266","volume":"233","author":"SE Enderami","year":"2018","unstructured":"Enderami, S. E., Soleimani, M., Mortazavi, Y., Nadri, S., & Salimi, A. (2018). Generation of insulin-producing cells from human adipose derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol. Journal of Cell Physiology, 233(5), 4327\u20134337. https:\/\/doi.org\/10.1002\/jcp.26266.","journal-title":"Journal of Cell Physiology"},{"issue":"5","key":"10036_CR97","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00005-015-0340-3","volume":"63","author":"M Pokrywczynska","year":"2015","unstructured":"Pokrywczynska, M., Lewandowska, M. A., Krzyzanowska, S., Jundzill, A., Rasmus, M., Warda, K., et al. (2015). Transdifferentiation of bone marrow mesenchymal stem cells into the islet-like cells: The role of extracellular matrix proteins. Archivum immunologiae et therapiae experimentalis (Warsz), 63(5), 377\u2013384. https:\/\/doi.org\/10.1007\/s00005-015-0340-3.","journal-title":"Archivum immunologiae et therapiae experimentalis (Warsz)"},{"issue":"4","key":"10036_CR98","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.bbrc.2005,03.111","volume":"330","author":"KS Choi","year":"2005","unstructured":"Choi, K. S., Shin, J. S., Lee, J. J., Kim, Y. S., Kim, S. B., & Kim, C. W. (2005). In vitro transdifferentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochemical and Biophysical Research Communications, 330(4), 1299\u20131305. https:\/\/doi.org\/10.1016\/j.bbrc.2005,03.111.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10036_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076056","volume":"8","author":"H Xie","year":"2013","unstructured":"Xie, H., Wang, Y., Zhang, H., Qi, H., Zhou, H., & Li, F. R. (2013). Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells. PLoS One, 8(9), e76056. https:\/\/doi.org\/10.1371\/journal.pone.0076056.","journal-title":"PLoS One"},{"issue":"8","key":"10036_CR100","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4172\/jpb.1000275","volume":"6","author":"H Xie","year":"2013","unstructured":"Xie, H., Zhang, H., Qi, H., Wang, Y., Deng, C., & Li, F. R. (2013). Discovery of novel proteins form injured rat pancreatic extract using MALDI-TOF\/MS- based proteomics. Journal of Proteomics & Bioinformatics, 6(8), 158\u2013163. https:\/\/doi.org\/10.4172\/jpb.1000275.","journal-title":"Journal of Proteomics & Bioinformatics"},{"key":"10036_CR101","doi-asserted-by":"publisher","first-page":"7103053","DOI":"10.1155\/2020\/7103053","volume":"2020","author":"MM Gabr","year":"2020","unstructured":"Gabr, M. M., Zakaria, M. M., Refaie, A. F., Khater, S. M., Ashamallah, S. A., Rashed, S. A., et al. (2020). PRDX6 promotes the differentiation of human mesenchymal stem (stromal) cells to insulin-producing cells. Biomed Research International, 2020, 7103053. https:\/\/doi.org\/10.1155\/2020\/7103053.","journal-title":"Biomed Research International"},{"issue":"5","key":"10036_CR102","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11892-011-0216-9","volume":"11","author":"E Cantarelli","year":"2011","unstructured":"Cantarelli, E., & Piemonti, L. (2011). Alternative transplantation sites for pancreatic islet grafts. Current Diabetes Reports, 11(5), 364\u2013374. https:\/\/doi.org\/10.1007\/s11892-011-0216-9.","journal-title":"Current Diabetes Reports"},{"issue":"5","key":"10036_CR103","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11892-013-0412-x","volume":"13","author":"S V\u00e9riter","year":"2013","unstructured":"V\u00e9riter, S., Gianello, P., & Dufrane, D. (2013). Bioengineered sites for islet cell transplantation. Current Diabetes Reports, 13(5), 745\u2013755. https:\/\/doi.org\/10.1007\/s11892-013-0412-x.","journal-title":"Current Diabetes Reports"},{"issue":"3","key":"10036_CR104","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ten.TEB.2017.0311","volume":"24","author":"H Zhu","year":"2018","unstructured":"Zhu, H., Li, W., Liu, Z., Li, W., Chen, N., Lu, L., et al. (2018). Selection of implantation sites for transplantation of encapsulated pancreatic islets. Tissue Engineering Part B: Reviews, 24(3), 191\u2013214. https:\/\/doi.org\/10.1089\/ten.TEB.2017.0311.","journal-title":"Tissue Engineering Part B: Reviews"},{"issue":"3","key":"10036_CR105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/sctm.18-0156","volume":"8","author":"CA Welsch","year":"2019","unstructured":"Welsch, C. A., Rust, W. L., & Csete, M. (2019). Concise Review: lessons learned from islet transplant clinical trials in developing stem cell therapies for type 1 diabetes. Stem Cells Translational Medicine, 8(3), 209\u2013214. https:\/\/doi.org\/10.1002\/sctm.18-0156.","journal-title":"Stem Cells Translational Medicine"},{"issue":"5","key":"10036_CR106","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nbt.3211","volume":"33","author":"AR Pepper","year":"2015","unstructured":"Pepper, A. R., Gala-Lopez, B., Pawlick, R., Merani, S., Kin, T., & Shapiro, J. (2015). A Prevascularized subcutaneous device-less site for islet and cellular transplantation. Nature Biotechnology, 33(5), 518\u2013523. https:\/\/doi.org\/10.1038\/nbt.3211.","journal-title":"Nature Biotechnology"},{"issue":"5","key":"10036_CR107","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3727\/096368910X536527","volume":"20","author":"J Svensson","year":"2011","unstructured":"Svensson, J., Lau, J., Sandberg, M., & Carlsson, P. O. (2011). High vascular density and oxygenation of pancreatic islets transplanted in clusters into striated muscle. Cell Transplantation, 20(5), 783\u2013788. https:\/\/doi.org\/10.3727\/096368910X536527.","journal-title":"Cell Transplantation"},{"issue":"2","key":"10036_CR108","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00007890-198308000-00014","volume":"36","author":"Y Yasunami","year":"1983","unstructured":"Yasunami, Y., Lacy, P. E., & Finke, E. H. (1983). A New site for islet transplantation--a peritoneal-omental pouch. Transplantation, 1983, 36(2), 181\u2013182. https:\/\/doi.org\/10.1097\/00007890-198308000-00014.","journal-title":"Transplantation, 1983"},{"issue":"2","key":"10036_CR109","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3346\/jkms.2010.25.2\/203","volume":"25","author":"HI Kim","year":"2010","unstructured":"Kim, H. I., Yu, J. Y., Park, C. G., & Kim, & S. J. (2010). Comparison of four pancreatic islet implantation sites. Journal of Korean Medical Science, 25(2), 203\u2013210. https:\/\/doi.org\/10.3346\/jkms.2010.25.2\/203.","journal-title":"Journal of Korean Medical Science"},{"issue":"12","key":"10036_CR110","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/TP.0b013e3182a6ee41","volume":"96","author":"K Bartholomeus","year":"2013","unstructured":"Bartholomeus, K., Thevissen, D. J., Shouyue, S., Suenens, K., In't Veld, P. A., Marichal, M. P., Pipeleers, D. G., et al. (2013). Omentum is better site than kidney capsule for growth, differentiation, and vascularization of immature porcine \u03b2-cell implants in immunodeficient rats. Transplantation, 96(12), 1026\u20131033. https:\/\/doi.org\/10.1097\/TP.0b013e3182a6ee41.","journal-title":"Transplantation"},{"issue":"5","key":"10036_CR111","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2337\/db15-1525","volume":"65","author":"BM Berman","year":"2016","unstructured":"Berman, B. M., Molano, R. D., Fotino, C., Ulissi, U., Gimeno, J., et al. (2016). Bioengineering the endocrine pancreas: intraomental islet transplantation within a biologic resorbable scaffold. Diabetes, 65(5), 1350\u20131361. https:\/\/doi.org\/10.2337\/db15-1525.","journal-title":"Diabetes"},{"issue":"19","key":"10036_CR112","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMc1613959","volume":"376","author":"DA Baidal","year":"2017","unstructured":"Baidal, D. A., Ricordi, C., Berman, D. M., Alvarez, A., Padilla, N., Ciancio, G., et al. (2017). Bioengineering of an Intraabdominal Endocrine Pancreas. New England Journal of Medicine, 376(19), 1887\u20131889. https:\/\/doi.org\/10.1056\/NEJMc1613959.","journal-title":"New England Journal of Medicine"},{"issue":"4472","key":"10036_CR113","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1126\/science.6776628","volume":"210","author":"F Lim","year":"1980","unstructured":"Lim, F., & Sun, A. M. (1980). Microencapsulated islets as bioartificial endocrine pancreas. Science, 210(4472), 908\u2013910. https:\/\/doi.org\/10.1126\/science.6776628.","journal-title":"Science"},{"issue":"9","key":"10036_CR114","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1517\/14712598.2015.1055242","volume":"15","author":"AA Tomei","year":"2015","unstructured":"Tomei, A. A., Villa, C., & Ricordi, C. (2015). Development of an encapsulated stem cell-based therapy for diabetes. Expert Opinion on Biological Therapy, 15(9), 1321\u20131336. https:\/\/doi.org\/10.1517\/14712598.2015.1055242.","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10036_CR115","doi-asserted-by":"publisher","unstructured":"de Groot, M., Schuurs, T. A., van Schilfgaarde, R. (20040. Causes of limited survival of microencapsulated pancreatic islet grafts. Journal of Surgical Research, 121(1), 141-150. https:\/\/doi.org\/10.1016\/j.jss.2004.02.018","DOI":"10.1016\/j.jss.2004.02.018"},{"issue":"8903","key":"10036_CR116","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/s0140-6736(94)90067-1","volume":"343","author":"P Soon-Shiong","year":"1994","unstructured":"Soon-Shiong, P., Heintz, R. E., Merideth, N., Yao, Q. X., Yao, Z., et al. (1994). Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet, 343(8903), 950\u2013951. https:\/\/doi.org\/10.1016\/s0140-6736(94)90067-1.","journal-title":"Lancet"},{"issue":"23","key":"10036_CR117","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1016\/j.biomaterials.2013.04.016","volume":"34","author":"TT Dang","year":"2013","unstructured":"Dang, T. T., Thai, A. V., Cohen, J., Slosberg, J. E., Siniakowicz, K., Doloff, J. C., et al. (2013). Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. Biomaterials, 34(23), 5792\u20135801. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.04.016.","journal-title":"Biomaterials"},{"issue":"29","key":"10036_CR118","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1073\/pnas.1402216111","volume":"111","author":"AA Tomei","year":"2014","unstructured":"Tomei, A. A., Manzoli, V., Fraker, C. A., Giraldo, J., Velluto, D., Najjar, M., et al. (2014). Device design and materials optimization of conformal coating for islets of langerhans. Proceedings of the National Academy of Sciences of the United States of America, 111(29), 10514\u201310519. https:\/\/doi.org\/10.1073\/pnas.1402216111.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10036_CR119","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nmat4290","volume":"14","author":"O Veiseh","year":"2015","unstructured":"Veiseh, O., Doloff, J. C., Ma, M., Vegas, A. J., Tam, H. H., Bader, A. R., et al. (2015). Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nature Materials, 14(6), 643\u2013651. https:\/\/doi.org\/10.1038\/nmat4290.","journal-title":"Nature Materials"},{"issue":"3","key":"10036_CR120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nbt.3462","volume":"34","author":"AJ Vegas","year":"2016","unstructured":"Vegas, A. J., Veiseh, O., Doloff, J. C., Ma, M., Tam, H. H., Bratlie, K., et al. (2016). Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nature Biotechnology, 34(3), 345\u2013352. https:\/\/doi.org\/10.1038\/nbt.3462.","journal-title":"Nature Biotechnology"},{"issue":"3","key":"10036_CR121","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas, A. J., Veiseh, O., G\u00fcrtler, M., Millman, J. R., Pagliuca, F. W., Bader, A. R., et al. (2016). Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nature medicine, 22(3), 306\u2013311. https:\/\/doi.org\/10.1038\/nm.4030.","journal-title":"Nature medicine"},{"issue":"1","key":"10036_CR122","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1900\/RDS.2017.14.51","volume":"14","author":"V Vaithilingam","year":"2017","unstructured":"Vaithilingam, V., Bal, S., & Tuch, B. E. (2017). Encapsulated islet transplantation: where do we stand? The Review of Diabetic Studies, 14(1), 51\u201378. https:\/\/doi.org\/10.1900\/RDS.2017.14.51.","journal-title":"The Review of Diabetic Studies"},{"key":"10036_CR123","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2741\/4195","volume":"19","author":"J Schweicher","year":"2014","unstructured":"Schweicher, J., Nyitray, C., & Desai, T. A. (2014). Membranes to achieve immunoprotection of transplanted islets. Frontiers in bioscience (Landmark Ed), 19, 49\u201376. https:\/\/doi.org\/10.2741\/4195.","journal-title":"Frontiers in bioscience (Landmark Ed)"},{"issue":"8","key":"10036_CR124","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11892-018-1028-y","volume":"18","author":"AJ Hwa","year":"2018","unstructured":"Hwa, A. J., & Weir, G. C. (2018). Transplantation of macroencapsulated insulin-producing cells. Current Diabetes Reports, 18(8), 50. https:\/\/doi.org\/10.1007\/s11892-018-1028-y.","journal-title":"Current Diabetes Reports"},{"issue":"4","key":"10036_CR125","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3727\/000000003108746957","volume":"12","author":"E Rafael","year":"2003","unstructured":"Rafael, E., Wu, G. S., Hultenby, K., Tibell, A., & Wernerson, A. (2003). Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study. Cell Transplantation, 12(4), 407\u2013412. https:\/\/doi.org\/10.3727\/000000003108746957.","journal-title":"Cell Transplantation"},{"issue":"2","key":"10036_CR126","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/TP.0b013e31817efc78","volume":"86","author":"AK S\u00f6renby","year":"2008","unstructured":"S\u00f6renby, A. K., Kumagai-Braesch, M., Sharma, A., Hultenby, K. R., Wernerson, A. M., & Tibell, A. B. (2008). Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model. Transplantation, 86(2), 364\u2013366. https:\/\/doi.org\/10.1097\/TP.0b013e31817efc78.","journal-title":"Transplantation"},{"issue":"9","key":"10036_CR127","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3727\/096368912X657873","volume":"22","author":"CA Fraker","year":"2013","unstructured":"Fraker, C. A., Cechin, S., \u00c1lvarez-Cubela, S., Echeverri, F., Bernal, A., Poo, R., et al. (2013). A physiological pattern of oxygenation using perfluorocarbon-based culture devices maximizes pancreatic islet viability and enhances \u03b2-cell function. Cell Transplantation, 22(9), 1723\u20131733. https:\/\/doi.org\/10.3727\/096368912X657873.","journal-title":"Cell Transplantation"},{"key":"10036_CR128","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biomaterials.2017.03.018","volume":"129","author":"MM Coronel","year":"2017","unstructured":"Coronel, M. M., Geusz, R., & Stabler, C. L. (2017). Mitigating hypoxic stress on pancreatic islets via in situ oxygen generating biomaterial. Biomaterials, 129, 139\u2013151. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.018.","journal-title":"Biomaterials"},{"issue":"6","key":"10036_CR129","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3727\/000000003108747109","volume":"12","author":"S Sigrist","year":"2003","unstructured":"Sigrist, S., Mechine-Neuville, A., Mandes, K., Calenda, V., Braun, S., Legeay, G., et al. (2003). Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplantation, 12(6), 627\u2013635. https:\/\/doi.org\/10.3727\/000000003108747109.","journal-title":"Cell Transplantation"},{"issue":"19","key":"10036_CR130","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1016\/j.biomaterials.2013.03.012","volume":"34","author":"EA Phelps","year":"2013","unstructured":"Phelps, E. A., Headen, D. M., Taylor, W. R., Thul\u00e9, P. M., & Garc\u00eda, A. J. (2013). Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes. Biomaterials, 34(19), 4602\u20134611. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.03.012.","journal-title":"Biomaterials"},{"issue":"6","key":"10036_CR131","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700184","volume":"3","author":"JD Weaver","year":"2017","unstructured":"Weaver, J. D., Headen, D. M., Aquart, J., Johnson, C. T., Shea, L. D., Shirwan, H., et al. (2017). Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites. Science Advances, 3(6), e1700184. https:\/\/doi.org\/10.1126\/sciadv.1700184.","journal-title":"Science Advances"},{"issue":"4","key":"10036_CR132","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/aor.12892","volume":"41","author":"FL Pape","year":"2017","unstructured":"Pape, F. L., Cosnuau-Kemmat, L., Richard, G., Dubrana, F., Claude F\u00e9rec, C., Zal, F., et al. (2017). HEMOXCell, a new oxygen carrier usable as an additive for mesenchymal stem cell culture in platelet lysate-supplemented media. Artificial Organs, 41(4), 359\u2013371. https:\/\/doi.org\/10.1111\/aor.12892.","journal-title":"Artificial Organs"},{"issue":"23-24","key":"10036_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ten.TEA.2016.0064","volume":"22","author":"A Rodriguez-Brotons","year":"2016","unstructured":"Rodriguez-Brotons, A., Bietiger, W., Peronet, C., Langlois, A., Magisson, J., Mura, C., et al. (2016). Comparison of perfluorodecalin and HEMOXCell as oxygen carriers for islet oxygenation in an in vitro model of encapsulation. Tissue Engineering Part A, 22(23-24), 1\u201331. https:\/\/doi.org\/10.1089\/ten.TEA.2016.0064.","journal-title":"Tissue Engineering Part A"},{"issue":"6B","key":"10036_CR134","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/j.1582-4934.2008.00322.x","volume":"12","author":"IR Sweet","year":"2009","unstructured":"Sweet, I. R., Yanay, O., Waldron, L., Gilbert, M., Fuller, J. M., Tupling, T., et al. (2009). Treatment of diabetic rats with encapsulated islets. Journal of Cellular and Molecular Medicine, 12(6B), 2644\u20132650. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00322.x.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"7","key":"10036_CR135","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3727\/096368912X657486","volume":"22","author":"M Kumagai-Braesch","year":"2013","unstructured":"Kumagai-Braesch, M., Jacobson, S., Mori, H., Jia, X., Takahashi, T., Wernerson, A., et al. (2013). The TheraCyte\u2122 device protects against islet allograft rejection in immunized hosts. Cell Transplantation, 22(7), 1137\u20131146. https:\/\/doi.org\/10.3727\/096368912X657486.","journal-title":"Cell Transplantation"},{"key":"10036_CR136","doi-asserted-by":"publisher","first-page":"E838","DOI":"10.1152\/ajpendo.00219.2014","volume":"307","author":"E Mott\u00e9","year":"2014","unstructured":"Mott\u00e9, E., Szepessy, E., Suenens, K., Stang\u00e9, G., Bomans, M., Jacobs-Tulleneers-Thevissen, D., et al. (2014). Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts. The American Journal of Physiology-Endocrinology and Metabolism, 307, E838\u2013E846. https:\/\/doi.org\/10.1152\/ajpendo.00219.2014.","journal-title":"The American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"3","key":"10036_CR137","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3727\/096368915X688939","volume":"25","author":"T Boettler","year":"2016","unstructured":"Boettler, T., Schneider, D., Cheng, Y., Kadoya, K., Brandon, E. P., Martinson, L., et al. (2016). Pancreatic tissue transplanted in TheraCyte encapsulation devices is protected and prevents hyperglycemia in a mouse model of immune-mediated diabetes. Cell Transplantation, 25(3), 609\u2013614. https:\/\/doi.org\/10.3727\/096368915X688939.","journal-title":"Cell Transplantation"},{"issue":"6","key":"10036_CR138","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/0963689718759913","volume":"27","author":"MM Gabr","year":"2018","unstructured":"Gabr, M. M., Zakaria, M. M., Refaie, A. F., Ismail, A. M., Khater, S. M., Ashamallah, S. A., et al. (2018). Insulin-producing cells from adult human bone marrow mesenchymal stromal cells could control chemically induced diabetes in dogs: A preliminary study. Cell Transplantation, 27(6), 937\u2013947. https:\/\/doi.org\/10.1177\/0963689718759913.","journal-title":"Cell Transplantation"},{"issue":"5","key":"10036_CR139","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1152\/ajpendo.00279.2010","volume":"299","author":"AV Matveyenko","year":"2010","unstructured":"Matveyenko, A. V., Georgia, A., & Bhushan, A\/ & Butler, P. C. (2010). Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats. The American Journal of Physiology-Endocrinology and Metabolism, 299(5), E13\u2013E20. https:\/\/doi.org\/10.1152\/ajpendo.00279.2010.","journal-title":"The American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"9","key":"10036_CR140","doi-asserted-by":"publisher","first-page":"E838","DOI":"10.1152\/ajpendo.00219.2014","volume":"307","author":"E Mott\u00e9","year":"2014","unstructured":"Mott\u00e9, E., Szepessy, E., Suenens, K., Stang\u00e9, G., Bomans, M., Jacobs-Tulleneers-Thevissen, D., et al. (2014). Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts. The American Journal of Physiology-Endocrinology and Metabolism, 307(9), E838\u2013E846. https:\/\/doi.org\/10.1152\/ajpendo.00219.2014.","journal-title":"The American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"8","key":"10036_CR141","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/TP.0000000000002217","volume":"102","author":"J Odorico","year":"2018","unstructured":"Odorico, J., Markmann, J., Melton, D., Greenstein, J., Hwa, A., Nostro, C., et al. (2018). Report of the key opinion leaders meeting on stem cell-derived beta cells. Transplantation, 2018, 102(8), 1223\u20131229. https:\/\/doi.org\/10.1097\/TP.0000000000002217.","journal-title":"Transplantation, 2018"},{"issue":"11","key":"10036_CR142","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/TP.0000000000000864","volume":"99","author":"AR Pepper","year":"2015","unstructured":"Pepper, A. R., Pawlick, R., Gala-Lopez, B., MacGillivary, A., Mazzuca, D. M., White, D. J., et al. (2015). Diabetes is reversed in a murine model by marginal mass syngeneic islet transplantation using a subcutaneous cell pouch device. Transplantation, 99(11), 2294\u20132300. https:\/\/doi.org\/10.1097\/TP.0000000000000864.","journal-title":"Transplantation"},{"key":"10036_CR143","volume":"4","author":"BL Gala-Lopez","year":"2016","unstructured":"Gala-Lopez, B. L., Pepper, A. R., Dinyari, P., Malcolm, A. J., Kin, T., Pawlick, L. R., et al. (2016). Subcutaneous clinical islet transplantation in a prevascularized subcutaneous pouch \u2013 preliminary experience. Cell R,n,d, 4, e2132.","journal-title":"Cell R,n,d"},{"issue":"47","key":"10036_CR144","doi-asserted-by":"publisher","first-page":"19054","DOI":"10.1073\/pnas.1317561110","volume":"110","author":"B Ludwig","year":"2013","unstructured":"Ludwig, B., Reichel, A., Steffen, A., Zimerman, B., Schally, A. V., Block, N. L., et al. (2013). Transplantation of human islets without immunosuppression. Proceedings of the National Academy of Sciences of the United States of America, 110(47), 19054\u201319058. https:\/\/doi.org\/10.1073\/pnas.1317561110.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10036_CR145","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.2337\/db17-0065","volume":"66","author":"O Korsgren","year":"2017","unstructured":"Korsgren, O. (2017). Islet Encapsulation: Physiological Possibilities and Limitations. Diabetes, 66(7), 1748\u20131754. https:\/\/doi.org\/10.2337\/db17-0065.","journal-title":"Diabetes"},{"issue":"7","key":"10036_CR146","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1111\/ajt.14642","volume":"18","author":"PO Carlsson","year":"2018","unstructured":"Carlsson, P. O., Espes, D., Sedigh, A., Rotem, A., Zimerman, B., Grinberg, H., et al. (2018). Transplantation of macroencapsulated human islets within the bioartificial pancreas \u03b2air to patients with type 1 diabetes mellitus. American Journal of Transplantation, 18(7), 1735\u20131744. https:\/\/doi.org\/10.1111\/ajt.14642.","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10036_CR147","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.biomaterials.2010.10.036","volume":"32","author":"JT Daoud","year":"2011","unstructured":"Daoud, J. T., Petropavlovskaia, M. S., Patapas, J. M., Degrandpr\u00e9, C. E., Diraddo, R. W., Rosenberg, L., et al. (2011). Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials, 32(6), 1536\u20131542. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.10.036.","journal-title":"Biomaterials"},{"issue":"3","key":"10036_CR148","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00441-015-2140-9","volume":"361","author":"L Khorsandi","year":"2015","unstructured":"Khorsandi, L., Khodadadi, A., Nejad-Dehbashi, F., & Saremy, S. (2015). Three-dimensional differentiation of adipose-derived mesenchymal stem cells into insulin-producing cells. Cell and Tissue Research, 361(3), 745\u2013753. https:\/\/doi.org\/10.1007\/s00441-015-2140-9.","journal-title":"Cell and Tissue Research"},{"issue":"5","key":"10036_CR149","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1021\/acsbiomaterials.7b00912","volume":"4","author":"T Kasputis","year":"2018","unstructured":"Kasputis, T., Clough, D., Noto, F., Rychel, K., Dye, B., & Shea, L. D. (2018). Microporous polymer scaffolds for the transplantation of embryonic stem cell derived pancreatic progenitors to a clinically translatable site for the treatment of type I diabetes. ACS Biomaterials Science & Engineering, 4(5), 1770\u20131778. https:\/\/doi.org\/10.1021\/acsbiomaterials.7b00912.","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"6","key":"10036_CR150","doi-asserted-by":"publisher","first-page":"9917","DOI":"10.1002\/jcb.28274","volume":"120","author":"M Ojaghi","year":"2019","unstructured":"Ojaghi, M., Soleimanifar, F., Kazemi, A., Ghollasi, M., Soleimani, M., Nasoohi, N., et al. (2019). Electrospun poly-l-lactic acid\/polyvinyl alcohol nanofibers improved insulin-producing cell differentiation potential of human adipose-derived mesenchymal stem cells. Journal of Cellular Biochemistry, 120(6), 9917\u20139926. https:\/\/doi.org\/10.1002\/jcb.28274.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10036_CR151","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.dsx.2018.06.021","volume":"12","author":"AM Gharravi","year":"2018","unstructured":"Gharravi, A. M., Jafar, A., Ebrahimi, M., Mahmodi, A., Pourhashemi, E., Haseli, N., et al. (2018). Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus. Diabetes, Metabolic Syndrome, 12(6), 1133\u20131139. https:\/\/doi.org\/10.1016\/j.dsx.2018.06.021.","journal-title":"Diabetes, Metabolic Syndrome"},{"issue":"4","key":"10036_CR152","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1900\/RDS.2017.14.334","volume":"14","author":"N Kumar","year":"2018","unstructured":"Kumar, N., Joisher, H., & Ganguly, A. (2018). Polymeric scaffolds for pancreatic tissue engineering: a review. Review of Diabetic Studies, 14(4), 334\u2013353. https:\/\/doi.org\/10.1900\/RDS.2017.14.334.","journal-title":"Review of Diabetic Studies"},{"issue":"3","key":"10036_CR153","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/ma12030363","volume":"12","author":"IJ Hall Barrientos","year":"2019","unstructured":"Hall Barrientos, I. J., MacKenzie, G. R., Wilson, C. G., Lamprou, D. A., & Coats, P. (2019). Biological performance of electrospun polymer fibres. Materials (Basel), 12(3), 363. https:\/\/doi.org\/10.3390\/ma12030363.","journal-title":"Materials (Basel)"},{"key":"10036_CR154","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41578-018-0057-0","volume":"3","author":"N Mitrousis","year":"2018","unstructured":"Mitrousis, N., Fokina, A., & Shoichet, M. S. (2018). Biomaterials for cell transplantation. Nature Reviews Materials, 3, 441\u2013456.","journal-title":"Nature Reviews Materials"},{"issue":"10","key":"10036_CR155","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1097\/TP.0b013e31816fc0ea","volume":"85","author":"DM Salvay","year":"2008","unstructured":"Salvay, D. M., Rives, C. B., Zhang, X., Chen, F., Kaufman, D. B., Lowe Jr., W. L., et al. (2008). Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation, 85(10), 1456\u20131464. https:\/\/doi.org\/10.1097\/TP.0b013e31816fc0ea.","journal-title":"Transplantation"},{"issue":"21-22","key":"10036_CR156","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1089\/ten.TEA.2013.0033","volume":"19","author":"WT Yap","year":"2013","unstructured":"Yap, W. T., Salvay, D. M., Silliman, M. A., Zhang, X., Bannon, Z. G., Kaufman, D. B., et al. (2013). Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia. Tissue Engineering Part A, 19(21-22), 2361\u20132372. https:\/\/doi.org\/10.1089\/ten.TEA.2013.0033.","journal-title":"Tissue Engineering Part A"},{"issue":"10","key":"10036_CR157","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.3727\/096368912X636786","volume":"21","author":"RB Vernon","year":"2012","unstructured":"Vernon, R. B., Preisinger, A., Gooden, M. D., D'Amico, L. A., Yue, B. B., Bollyky, P. L., et al. (2012). Reversal of diabetes in mice with a bioengineered islet implant incorporating a type i collagen hydrogel and sustained release of vascular endothelial growth factor. Cell Transplantation, 21(10), 2099\u20132110. https:\/\/doi.org\/10.3727\/096368912X636786.","journal-title":"Cell Transplantation"},{"issue":"7","key":"10036_CR158","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3727\/096368912X640574","volume":"21","author":"Y Asawa","year":"2012","unstructured":"Asawa, Y., Sakamoto, T., Komura, M., Watanabe, M., Nishizawa, S., Takazawa, Y., et al. (2012). Early stage foreign body reaction against biodegradable polymer scaffolds affects tissue regeneration during the autologous transplantation of tissue-engineered cartilage in the canine model. Cell Transplantation, 21(7), 1431\u20131442. https:\/\/doi.org\/10.3727\/096368912X640574.","journal-title":"Cell Transplantation"},{"key":"10036_CR159","doi-asserted-by":"publisher","unstructured":"Goh, S. K, Bertera, S., Olsen, P., Candiello, J. E., Halfter, W., Uechi, G., et al. (2013). Perfusion-decellularized pancreas as a natural 3d scaffold for pancreatic tissue and whole organ engineering. Biomaterials, 34(28), 6760-6772. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.05.066","DOI":"10.1016\/j.biomaterials.2013.05.066"},{"issue":"3","key":"10036_CR160","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jbm.820100308","volume":"10","author":"BF Matlaga","year":"1976","unstructured":"Matlaga, B. F., Yasenchak, L. P., & Salthouse, T. N. (1976). Tissue response to implanted polymers: the significance of sample shape. Journal of Biomedical Materials Research, 10(3), 391\u2013397. https:\/\/doi.org\/10.1002\/jbm.820100308.","journal-title":"Journal of Biomedical Materials Research"},{"key":"10036_CR161","doi-asserted-by":"publisher","unstructured":"Smink, A. M., Li, S., Hertsig, D. T., de Haan, B. J., Leendert Schwab, L., van Apeldoorn, A. A., de Koning, E., et al. (2017). The efficacy of a prevascularized, retrievable poly(d,l,-lactide-co-\u03b5-caprolactone) subcutaneous scaffold as transplantation site for pancreatic islets. Transplantation, 101(4), e112-e119. https:\/\/doi.org\/10.1097\/TP.0000000000001663","DOI":"10.1097\/TP.0000000000001663"},{"issue":"7","key":"10036_CR162","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3727\/096368912X657440","volume":"22","author":"E Pedraza","year":"2013","unstructured":"Pedraza, E., Brady, A. C., Fraker, C. A., Molano, R. D., Sukert, S., Berman, D. M., et al. (2013). Macroporous Three-dimensional PDMS scaffolds for extrahepatic islet transplantation. Cell Transplantation, 22(7), 1123\u20131135. https:\/\/doi.org\/10.3727\/096368912X657440.","journal-title":"Cell Transplantation"},{"issue":"12","key":"10036_CR163","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.yexcr.2006.03.019","volume":"312","author":"I Rasmusson","year":"2006","unstructured":"Rasmusson, I. (2006). Immune modulation by mesenchymal stem cells. Experimental Cell Research, 312(12), 2169\u20132179. https:\/\/doi.org\/10.1016\/j.yexcr.2006.03.019.","journal-title":"Experimental Cell Research"},{"issue":"10","key":"10036_CR164","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3727\/096368912X657369","volume":"22","author":"SA Jacobs","year":"2013","unstructured":"Jacobs, S. A., Pinxteren, J., Roobrouck, V. D., Luyckx, A., van't Hof, W., Deans, R., et al. (2013). Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses. Cell Transplantation, 22(10), 1915\u20131928. https:\/\/doi.org\/10.3727\/096368912X657369.","journal-title":"Cell Transplantation"},{"key":"10036_CR165","doi-asserted-by":"publisher","unstructured":"Le Blanc, K., & Davies, L. C. (2015). Mesenchymal stromal cells and the innate immune response Immunology Letters, 168(2), 140-146. https:\/\/doi.org\/10.1016\/j.imlet.2015.05.004","DOI":"10.1016\/j.imlet.2015.05.004"},{"issue":"3","key":"10036_CR166","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"WT Tse","year":"2003","unstructured":"Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., & Guinan, E. C. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75(3), 389\u2013397. https:\/\/doi.org\/10.1097\/01.TP.0000045055.63901.A9.","journal-title":"Transplantation"},{"issue":"5","key":"10036_CR167","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/eji.200425405","volume":"35","author":"A Augello","year":"2005","unstructured":"Augello, A., Tasso, R., Negrini, S. M., Amateis, A., Indiveri, F., Cancedda, R., et al. (2005). Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology, 35(5), 1482\u20131490. https:\/\/doi.org\/10.1002\/eji.200425405.","journal-title":"European Journal of Immunology"},{"issue":"9","key":"10036_CR168","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4252\/wjsc.v8.i9.268","volume":"8","author":"OK Ma","year":"2016","unstructured":"Ma, O. K., & Chan, K. H. (2016). Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes. World Journal of Stem Cells, 8(9), 268\u2013278. https:\/\/doi.org\/10.4252\/wjsc.v8.i9.268.","journal-title":"World Journal of Stem Cells"},{"issue":"8","key":"10036_CR169","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., et al. (2018). Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nature Reviews Nephrology, 14(8), 493\u2013507. https:\/\/doi.org\/10.1038\/s41581-018-0023-5.","journal-title":"Nature Reviews Nephrology"},{"key":"10036_CR170","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"AR Weiss","year":"2019","unstructured":"Weiss, A. R., & Dahlke, M. H. (2019). Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of action of Living, Apoptotic, and Dead MSCs. Frontiers in immunology, 10, 1191. https:\/\/doi.org\/10.3389\/fimmu.2019.01191.","journal-title":"Frontiers in immunology"},{"issue":"1","key":"10036_CR171","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/s0301-472x(01)00769-x","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., Mclntosh, K., Patil, S., et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology, 30(1), 42\u201348. https:\/\/doi.org\/10.1016\/s0301-472x(01)00769-x.","journal-title":"Experimental Hematology"},{"issue":"1","key":"10036_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","volume":"164","author":"M Shi","year":"2011","unstructured":"Shi, M., Liu, Z. W., & Wang, F. S. (2011). Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clinical & Experimental Immunology, 164(1), 1\u20138. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04327.x.","journal-title":"Clinical & Experimental Immunology"},{"issue":"1","key":"10036_CR173","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jocit.2014.12.001","volume":"2","author":"Q Zhao","year":"2016","unstructured":"Zhao, Q., Ren, H., & Han, Z. (2016). Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases. Journal of Cellular Immunotherapy, 2(1), 3\u201320. https:\/\/doi.org\/10.1016\/j.jocit.2014.12.001.","journal-title":"Journal of Cellular Immunotherapy"},{"issue":"1","key":"10036_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.327","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao, F., Chiu, S. M., Motan, D. A., Zhang, Z., Chen, L., Ji, H. L., et al. (2016). Mesenchymal stem cells and immunomodulation: Current status and future prospects. Cell Death & Disease, 7(1), e2062. https:\/\/doi.org\/10.1038\/cddis.2015.327.","journal-title":"Cell Death & Disease"},{"issue":"46","key":"10036_CR175","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., et al. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proceedings of the National Academy of Sciences of the United States of America, 103(46), 17438\u201317443. https:\/\/doi.org\/10.1073\/pnas.0608249103.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"10036_CR176","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","volume":"52","author":"AM Madec","year":"2009","unstructured":"Madec, A. M., Mallone, R., Afonso, G., Abou Mrad, E., Mesnier, A., Eljaafari, A., & al. (2009). Mesenchymal stem cells protect NOD Mice from diabetes by inducing regulatory T cell. Diabetologia, 52(7), 1391\u20131399. https:\/\/doi.org\/10.1007\/s00125-009-1374-z.","journal-title":"Diabetologia"},{"issue":"4","key":"10036_CR177","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3892\/etm.2017.4096","volume":"13","author":"XF Yang","year":"2017","unstructured":"Yang, X. F., Che, T., Ren, L. W., Yang, L., Qi, H., & Li, F. R. (2017). Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells. Experimental and Therapeutic Medicine, 13(4), 1456\u20131464. https:\/\/doi.org\/10.3892\/etm.2017.4096.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"6","key":"10036_CR178","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/01.tp.0000258649.23081.a3","volume":"83","author":"AJ Poncelet","year":"2007","unstructured":"Poncelet, A. J., Vercruysse, J., Saliez, A., & Gianello, P. (2007). Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation, 83(6), 783\u2013790. https:\/\/doi.org\/10.1097\/01.tp.0000258649.23081.a3.","journal-title":"Transplantation"},{"issue":"4","key":"10036_CR179","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/scrt488","volume":"5","author":"P Lohan","year":"2014","unstructured":"Lohan, P., Coleman, C. M., Murphy, J. M., Griffin, M. D., Ritter, T., & Ryan, A. E. (2014). Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should be concerned? Stem Cell Research & Therapy, 5(4), 99. https:\/\/doi.org\/10.1186\/scrt488.","journal-title":"Stem Cell Research & Therapy"},{"issue":"10","key":"10036_CR180","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jcyt.2016.07.006","volume":"18","author":"J Valencia","year":"2016","unstructured":"Valencia, J., Blanco, B., Y\u00e1\u00f1ez, R., V\u00e1zquez, M., S\u00e1nchez, C. H., Fern\u00e1ndez-Garc\u00eda, M., et al. (2016). Comparative analysis of the immunomodulatory capacities of human bone marrow-and adipose tissue-derived mesenchymal stromal cells from the same donor. Cytotherapy, 18(10), 1297\u20131311. https:\/\/doi.org\/10.1016\/j.jcyt.2016.07.006.","journal-title":"Cytotherapy"},{"issue":"4","key":"10036_CR181","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/cmi.2014.70","volume":"12","author":"LH Gu","year":"2015","unstructured":"Gu, L. H., Zhang, T. T., Li, Y., Yan, H. J., Qi, H., & Li, F. R. (2015). Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic rats. Cellular & Molecular Immunology, 12(4), 444\u2013455. https:\/\/doi.org\/10.1038\/cmi.2014.70.","journal-title":"Cellular & Molecular Immunology"},{"issue":"6","key":"10036_CR182","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","volume":"108","author":"AJ Nauta","year":"2006","unstructured":"Nauta, A. J., Westerhuis, G., Kruisselbrink, A. B., Lurvink, E. G., & Willemze, R.,& Fibbe, W. E. (2006). Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood, 108(6), 2114\u20132120. https:\/\/doi.org\/10.1182\/blood-2005-11-011650.","journal-title":"Blood"},{"issue":"3","key":"10036_CR183","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/14653249.2010.504769","volume":"13","author":"A Technau","year":"2011","unstructured":"Technau, A., Froelich, K., Hagen, R., & Kleinsasser, N. (2011). Adipose tissue-derived stem show both immunogenic and immunosuppressive properties after chondrogenic differentiation. Cytotherapy, 13(3), 310\u2013317. https:\/\/doi.org\/10.3109\/14653249.2010.504769.","journal-title":"Cytotherapy"},{"issue":"1","key":"10036_CR184","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-017-0742-8","volume":"8","author":"AK Berglund","year":"2017","unstructured":"Berglund, A. K., Fortier, L. A., Antczak, D. F., & Schnabel, L. V. (2017). Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Research & Therapy, 8(1), 288. https:\/\/doi.org\/10.1186\/s13287-017-0742-8.","journal-title":"Stem Cell Research & Therapy"},{"issue":"11","key":"10036_CR185","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1432-2277.2008.00726.x","volume":"21","author":"ML del Rio","year":"2008","unstructured":"del Rio, M. L., Buhler, L., Gibbons, C., Tian, J., & Rodriguez-Barbosa, J. I. (2008). PD-1\/PD-L1, PD-1\/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transplant International, 21(11), 1015\u20131028. https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00726.x.","journal-title":"Transplant International"},{"issue":"3","key":"10036_CR186","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies, L. C., Heldring, N., Kadri, N., & Le Blanc, K. (2017). Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells, 35(3), 766\u2013776. https:\/\/doi.org\/10.1002\/stem.2509.","journal-title":"Stem Cells"},{"key":"10036_CR187","doi-asserted-by":"publisher","unstructured":"Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., et al. (2003). Critical role of the programmed death-1 ( PD-1 ) pathway in regulation of experimental autoimmune encephalomyelitis. Journal of Experimental Medicine, 198(1), 71-78. https:\/\/doi.org\/10.1084\/jem.20022119","DOI":"10.1084\/jem.20022119"},{"issue":"3","key":"10036_CR188","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCRESAHA.112.276501","volume":"112","author":"L Lauden","year":"2013","unstructured":"Lauden, L., Boukouaci, W., Borlado, L. R., L\u00f3pez, I. P., Sep\u00falveda, P., Tamouza, R., et al. (2013). Allogenicity of human cardiac stem\/progenitor cells orchestrated by programmed death ligand 1. Circulation Research, 112(3), 451\u2013464. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.276501.","journal-title":"Circulation Research"},{"issue":"3","key":"10036_CR189","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/tan.12614","volume":"86","author":"R Al-Daccak","year":"2015","unstructured":"Al-Daccak, R., & Charron, D. (2015). Allogenic benefit in stem cell therapy: cardiac repair and regeneration. Tissue Antigens, 86(3), 155\u2013162. https:\/\/doi.org\/10.1111\/tan.12614.","journal-title":"Tissue Antigens"},{"key":"10036_CR190","doi-asserted-by":"publisher","first-page":"41125","DOI":"10.1038\/srep411","volume":"7","author":"HR Hocine","year":"2017","unstructured":"Hocine, H. R., Costa, H. E., Dam, N., Giustiniani, J., Palacios, I., Loiseau, P., et al. (2017). Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem\/progenitor cells. Scientific Reports, 7, 41125. https:\/\/doi.org\/10.1038\/srep411.","journal-title":"Scientific Reports"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-020-10036-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-020-10036-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:14:03Z","timestamp":1723508043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-020-10036-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":190,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10036"],"URL":"https:\/\/doi.org\/10.1007\/s12015-020-10036-3","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"3 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}